Ursula Mirastschijski (Former)

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/258dde19-a087-4a4c-ba1f-068490c11106?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2004
Mark Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds.
Mirastschijski, Ursula ^LU ; Haaksma, Carol J ; Tomasek, James J and Agren, Magnus S (2004) In Experimental Cell Research 299(2). p.465-475
- Contribution to journal › Article
2002
Mark Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
Mirastschijski, Ursula ^LU ; Impola, Ulla ; Karsdal, Morten A ; Saarialho-Kere, Ulpu and Agren, Magnus S (2002) In Journal of Investigative Dermatology 118(1). p.55-64
- Contribution to journal › Article
Mark Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.
Mirastschijski, Ursula ^LU ; Impola, Ulla ; Jahkola, Tiina ; Karlsmark, Tonny ; AGren, Magnus S and Saarialho-Kere, Ulpu (2002) In Human Pathology 33(3). p.355-364
- Contribution to journal › Article